A Randomized Encouragement Trial to Increase Mail Order Pharmacy Use and Medication Adherence in Patients with Diabetes

Autor: Julie A. Schmittdiel, Wendy Dyer, Bharathi Ramachandran, Dennis Ross-Degnan, J. Frank Wharam, Deanne Wiley, Cassondra Marshall, Romain Neugebauer, O. Kenrik Duru, Susan D. Brown, Andrew J. Karter, Connie Mah Trinacty
Rok vydání: 2020
Předmět:
medicine.medical_specialty
Clinical Trials and Supportive Activities
Clinical Sciences
Psychological intervention
Pharmacy
01 natural sciences
Hawaii
Medication Adherence
encouragement trial
03 medical and health sciences
0302 clinical medicine
7.1 Individual care needs
Clinical Research
General & Internal Medicine
Diabetes mellitus
Internal medicine
Intervention (counseling)
Behavioral and Social Science
Health care
Diabetes Mellitus
Internal Medicine
medicine
Humans
Postal Service
030212 general & internal medicine
0101 mathematics
Metabolic and endocrine
Original Research
mail order pharmacy
diabetes
business.industry
Telephone call
010102 general mathematics
Health Services
medicine.disease
Metformin
Outreach
Good Health and Well Being
Management of diseases and conditions
business
medicine.drug
Zdroj: J Gen Intern Med
Journal of general internal medicine, vol 36, iss 1
ISSN: 1525-1497
0884-8734
DOI: 10.1007/s11606-020-06237-8
Popis: BACKGROUND: Mail order pharmacy (MOP) use has been linked to improved medication adherence and health outcomes among patients with diabetes. However, no large-scale intervention studies have assessed the effect of encouraging MOP use on medication adherence. OBJECTIVE: To assess an intervention to encourage MOP services to increase its use and medication adherence. DESIGN: Randomized encouragement trial. PATIENTS: 63,012 diabetes patients from three health care systems: Kaiser Permanente Northern California (KPNC), Kaiser Permanente Hawaii (KPHI), and Harvard Pilgrim Health Care (HPHC) who were poorly adherent to at least one class of cardiometabolic medications and had not used MOP in the prior 12 months. INTERVENTION: Patients were randomized to receive either usual care (control arm) or outreach encouraging MOP use consisting of a mailed letter, secure email message, and automated telephone call outlining the potential benefits of MOP use (intervention arm). HPHC intervention patients received the letter only. MEASUREMENTS: We compared the percentages of patients that began using MOP and that became adherent to cardiometabolic medication classes during a 12-month follow-up period. We also conducted a race/ethnicity-stratified analysis. RESULTS: During follow-up, 10.6% of intervention patients began using MOP vs. 9.3% of controls (p
Databáze: OpenAIRE